Jyothy Labs Ltd (JYOTHYLAB) Q3FY25 Concall Summary - Dec-2024 Qtr
Performance Overview
- Jyothy Labs reported consolidated revenue from operations of INR704 crores, a 4% year-on-year value growth and 8% volume growth. The difference is attributed to higher grammages and promotional pricing.
- Excluding the Household Insecticides (HI) segment, value growth was 6.1% and volume growth was 10.3%.
- Overall demand remains subdued due to inflationary pressures and slow urban growth, partially offset by decent rural demand.
- Gross margin held steady at 49.8% year-on-year due to raw material coverage.
- The company maintained its advertising and sales promotion spend at 9% of revenue.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.